✦ LIBER ✦

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

✍ Scribed by Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; Jose Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez Rovira; Martine J Piccart-Gebhart

Book ID: 117300465
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 183 KB
Volume: 369
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(07)60028-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with trastuzumab for 1 year af

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB

Neoadjuvant chemotherapy with trastuzuma

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

✍ Luca Gianni; Wolfgang Eiermann; Vladimir Semiglazov; Alexey Manikhas; Ana Lluch; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 124 KB

Adjuvant trastuzumab in elderly with HER

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials

✍ Janaina Brollo; Giuseppe Curigliano; Davide Disalvatore; Bianca Fontana Marrone; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

A Meta-Analysis of Randomized Controlled

A Meta-Analysis of Randomized Controlled Trials Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Alone in HER-2-Positive Advanced Breast Cancer

✍ Cun Liao; Fang Yin; Ping Huang; Yunfei Cao; Feng Gao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

0154 TEACH: Phase III study of lapatinib

0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancer

✍ B. Moy; J.D. Maltzman; E. Rappold; L. Nicolodi; L.S. Williams; P.E. Goss 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Prevalence and management of HER2/neu-po

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab

✍ A. Chan; S. R. McGregor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB